Institut Mérieux, a French company that uses its expertise in industrial microbiology to serve medicine and worldwide public health, said it intends to create a center in China that combines R&D, bio-industrial and commercial activities. The China center will join Institut Mérieux’s two existing advanced bases of operations, one in the EU and the other in the US. The company said China has both high-level potential in biology and significant needs in public health. More details...